WallStreetZenWallStreetZen

NASDAQ: FDMT
4d Molecular Therapeutics Inc Stock Ownership - Who owns 4d Molecular Therapeutics?

Insider buying vs selling

Have 4d Molecular Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Scott BizilyChief Legal Officer2024-03-18500$6.49
$3.25kBuy
Scott BizilyChief Legal Officer2024-03-181,250$8.04
$10.05kBuy
Scott BizilyChief Legal Officer2024-03-181,750$31.27
$54.72kSell
Scott BizilyChief Legal Officer2024-02-271,909$30.00
$57.27kSell
Scott BizilyChief Legal Officer2024-02-271,909$20.24
$38.64kBuy
Scott BizilyChief Legal Officer2024-02-16500$6.49
$3.25kBuy
Scott BizilyChief Legal Officer2024-02-161,750$27.67
$48.42kSell
Scott BizilyChief Legal Officer2024-02-161,250$8.04
$10.05kBuy
Scott BizilyChief Legal Officer2024-02-082,916$27.50
$80.19kSell
Scott BizilyChief Legal Officer2024-02-082,916$8.04
$23.44kBuy

1 of 4

FDMT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FDMT insiders and whales buy or sell their stock.

FDMT Shareholders

What type of owners hold 4d Molecular Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Viking Global Investors LP9.62%4,787,914$171.74MInstitution
Viking Global Investors LP8.53%4,247,914$152.37MInsider
Ra Capital Management LP8.36%4,163,211$149.33MInstitution
Bvf Inc8.05%4,007,413$143.75MInstitution
Blackrock Inc6.96%3,464,587$124.27MInstitution
Vr Adviser LLC6.88%3,424,031$122.82MInstitution
Janus Henderson Group PLC6.21%3,093,296$110.96MInstitution
Deep Track Capital LP4.59%2,284,372$81.94MInstitution
Vanguard Group Inc3.75%1,866,849$66.96MInstitution
David Kirn3.33%1,659,153$59.51MInsider

1 of 3

FDMT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FDMT83.80%16.20%Net BuyingNet Selling
ZLAB4.15%1.95%Net BuyingNet Selling
KURA90.77%9.23%Net BuyingNet Selling
IRON44.60%55.40%Net SellingNet Selling
AGIO75.10%24.90%Net SellingNet Selling

4d Molecular Therapeutics Stock Ownership FAQ

Who owns 4d Molecular Therapeutics?

4d Molecular Therapeutics (NASDAQ: FDMT) is owned by 85.25% institutional shareholders, 16.47% 4d Molecular Therapeutics insiders, and 0.00% retail investors. Viking Global Investors LP is the largest individual 4d Molecular Therapeutics shareholder, owning 4.25M shares representing 8.53% of the company. Viking Global Investors LP's 4d Molecular Therapeutics shares are currently valued at $135.34M.

If you're new to stock investing, here's how to buy 4d Molecular Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.